Furthermore, the association of CXCL1 expressed in CAFs and clinicopathological parameters, as well as overall survival of ESCC patients treated with chemoradiotherapy was statistically analyzed. This evidence concerns the gene CXCL1 and esophageal squamous cell carcinoma.